|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| C07K 16/28 | (2006.01) |
| (11) | Number of the document | 2928923 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13814340.9 |
| Date of filing the European patent application | 2013-12-10 | |
| (97) | Date of publication of the European application | 2015-10-14 |
| (45) | Date of publication and mention of the grant of the patent | 2020-01-22 |
| (46) | Date of publication of the claims translation | 2020-02-25 |
| (86) | Number | PCT/US2013/074208 |
| Date | 2013-12-10 |
| (87) | Number | WO 2014/093396 |
| Date | 2014-06-19 |
| (30) | Number | Date | Country code |
| 201261735362 P | 2012-12-10 | US | |
| 201361763270 P | 2013-02-11 | US |
| (72) |
CARAVELLA, Justin A., US
GARBER STARK, Ellen A., US
RABAH, Dania Mounir, US
TAYLOR, Frederick R., US
|
| (73) |
Biogen MA Inc.,
225 Binney Street, Cambridge, MA 02142,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Anti-kraujo dendritinių ląstelių antigeno 2 antikūnai ir jų panaudojimas |
| ANTI-BLOOD DENDRITIC CELL ANTIGEN 2 ANTIBODIES AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2024-11-21 | 12 | 289.00 EUR |
| 2025-12-10 |